Improved survival time trends in Hodgkin's lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Improved survival time trends in Hodgkin's lymphoma

Published:2016-03-21 Issue:6 Volume:5 Page:997-1003
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Koshy Matthew¹²,Fairchild Andrew¹,Son Christina H.²,Mahmood Usama³

Affiliation:

1. Department of Radiation Oncology University of Illinois at Chicago Chicago Illinois 60637

2. Departments of Radiation and Cellular Oncology The University of Chicago Chicago Illinois 60637

3. Department of Radiation Oncology The University of Texas MD Anderson Cancer Center Houston Texas

Funder

Bucksbaum Institute for Clinical Excellence

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.655

Reference28 articles.

1. Improved survival in Hodgkin's disease

2. National Cancer Institute.Surveillance Epidemiology and End Results Program. SEER Stat Fact Sheets: Hodgkin Lymphoma. [accessed 9 2015].

3. Combined-Modality Therapy for Clinical Stage I or II Hodgkin's Lymphoma: Long-Term Results of the European Organisation for Research and Treatment of Cancer H7 Randomized Controlled Trials

4. Two Cycles of Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine Plus Extended-Field Radiotherapy Is Superior to Radiotherapy Alone in Early Favorable Hodgkin's Lymphoma: Final Results of the GHSG HD7 Trial

5. Low-Dose Involved Field Radiation after Chemotherapy in Advanced Hodgkin Disease: A Southwest Oncology Group Randomized Study

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Baseline prognostic predictors in classical Hodgkin Lymphoma: a retrospective, single-center analysis on patients treated with PET/CT-guided ABVD;Frontiers in Oncology;2024-09-05

2. The Effect of Diagnostic and Therapeutic Changes on the Survival of Hodgkin’s Lymphoma Patients (1980–2019);Medicina;2024-08-06

3. Long-term cardiac effects of modern treatment for Hodgkin’s lymphoma;Cardio-Oncology;2024-04-04

4. Long-term Cardiac Effects of Modern Treatment for Hodgkin’s Lymphoma;2024-01-02

5. Representation of the population in need for pivotal clinical trials in lymphomas;Blood;2023-08-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3